The E119D neuraminidase (NA) mutation confers pan-resistance to NA inhibitors in A(H1N1)pdm09.
E119D and E119D/H275Y A(H1N1)pdm09 mutants had a compromised fitness in vitro and in vivo.
D119E reversions occurred in mutants during in vitro passages and in infected animals.